Research
The research areas of the Kohlbacher Lab are rather diverse and span from classical bioinformatics topics including sequence, structure, and systems bioinformatics to translational bioinformatics and personalized medicine. The following list gives an overview of our current research areas and provides links to more detailed information pages on our current projects.
Computational Immunomics
Computational immunomics applies bioinformatics methods to gain a deeper understanding of the immune system. Furthermore it assists medical research by providing computational models which help to solve immunology-related problems. Our group develops various computational immunomics methods, primarily for mass spectrometry (MHC ligandomics) and NGS (HLA typing, neoepitope discovery) based analyses.
More on our current projects can be found here.
Computational Mass Spectrometry and Metabolomics
We are focused on development and integration of analysis pipelines for molecular tumor table backends mainly centered around high-throughput data extraction and integration, automated processing of incoming data, annotation of therapeutic options and
More on our current projects can be found here.
Personalized Medicine
We are focused on development and integration of analysis pipelines for molecular tumor table backends mainly centered around high-throughput data extraction and integration, automated processing of incoming data, annotation of therapeutic options and
More on our current projects can be found here.
Structural Bioinformatics
Structural Bioinformatics is one of the
More on our current projects can be found here.
Translational Bioinformatics
Translational Bioinformatics is a field at the interface of bioinformatics and medical informatics. By integrating molecular data (bioinformatics) and healthcare data (medical informatics), it becomes possible to identify identify new pathomechanisms, suggest personalized therapies, or enable machine learning on medical data. Current projects include the development of infrastructures and methods to enable molecular tumor boards and new methods for distributed, privacy-preserving data analytics.
More on our current projects can be found here.